FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16450411000001109: Zinnat 250mg tablets (Lexon (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57577901000001119 Zinnat 250mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57578001000001117 Zinnat 250mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zinnat 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Is a Cefuroxime 250mg tablets true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Is a Cefuroxime 250mg tablets false Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Is a Product containing precisely cefuroxime 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has active ingredient Cefuroxime false Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has specific active ingredient Cefuroxime axetil true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefuroxime true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Is a Zinnat true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zinnat 250mg tablets (Lexon (UK) Ltd) Has basis of strength substance Cefuroxime true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zinnat 250mg tablets (Lexon (UK) Ltd) 14 tablet Has AMP True Zinnat 250mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start